Tagged: Rectal Cancer

New Paper Compares MR Methods for Tumour Perfusion

Acredit’s Kine Bakke has published an article looking into the use of MR technology in the diagnosis of physical features of colorectal tumours. Kine’s publication compares different MR-based methods for quantification of the functionality...

New exosome paper from CMOR group

Tonje Bjørnetrø of the CMOR research group has published a paper entitled “An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer”. Tonje’s...

Immune Effectors in Colorectal Cancer

Immune Effectors in Colorectal Cancer

Immune effectors in colorectal cancer. A recent publication from ACREDIT describes how systemic release of osteoprotegerin during oxaliplatincontaining induction chemotherapy favors systemic outcome of sequential radiotherapy in rectal cancer. LINK  

Kine Marie Bakke’s First Publication

Kine Marie Bakke’s First Publication

One of Acredit’s young researchers, Kine Mari Bakke, published her first article ” Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival” in Acta Oncologica this...

ACREDIT Member Defends PhD Thesis

ACREDIT Member Defends PhD Thesis

ACREDIT member Helga H Hektoen brilliantly defended her PhD thesis “Translational studies of microenvironmental factors in rectal cancer with emphasis on tumor hypoxia” on the 29th of October 2015 at Akershus University Hospital. Doctoral...